NewsFirst AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuestTM, Receives FDA ClearanceDecember 13, 2022
NewsCould an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?December 7, 2022
News, RecognitionAvenda Health Adds Tech Luminary to Board of Directors and Expands Leadership TeamAugust 26, 2022
News, RecognitionAvenda Health Granted FDA Breakthrough Device Designation for Technology to Treat Prostate CancerMay 11, 2021
NewsEnrollment begins for prostate cancer trial using the Avenda Health Focal Laser Ablation SystemMay 18, 2020